Abstract: A foetal monitoring device for simultaneously monitoring a concentration of an analyte in a foetus and a heart rate of the foetus, the device comprising a biosensor and an electrocardiogram (ECG).

Abstract: The present invention relates to an anti-transglutaminase type 2 (TG2) antibody for use in the treatment of a scleroderma disease, such as localized or systemic scleroderma.

Abstract: A Global Navigation Satellite System (GNSS) patch antenna can include a middle laminate, a top laminate, a bottom laminate, and a ground well. The middle laminate can include a first side and a second side. The top laminate can be coupled to the middle laminate and can be positioned on the first side of the middle laminate. The top laminate can include an electrically conductive antenna element configured to receive GNSS signals. The bottom laminate can be coupled to the middle laminate and can be positioned on the second side of the middle laminate. The ground well can cover exposed surfaces of the bottom laminate and exposed portions of the second side of the middle laminate and can comprise electrically conductive material. Some of the surface of the middle laminate that is covered by the bottom laminate can be free from the electrically conductive material.

Abstract: Systems and methods which provide tokenization of various shipping data for which shielding is desired are described. Embodiments may facilitate controlled and/or protected usage of shielded shipping data, such as may include personally identifiable information, with tokenization. Shielded shipping data tokens of embodiments are matched with an entity, party, system, permitted usage of corresponding shielded shipping data. A data shielding service system may shield usage of shielded shipping data in accordance with applicable regulations according to applicable rules, and/or the like. Permitted accessors may be relieved of demands of maintaining compliance with the regulations and rules with respect to shielded shipping data in light of their enforcement and compliance being imposed through tokenization of the shielded shipping data.

Abstract: Exemplary embodiments of the present invention would determine exemplary projected routes, delivery dates, times and rates for multiple carriers and multiple delivery services/methods. Exemplary embodiments would generate and provide an exemplary interactive graphic comparison mapping of the exemplary projected carrier-specific, delivery-service-specific routes, and associated projected delivery dates, times and rates. Exemplary embodiments of the present invention would generate and provide an exemplary interactive graphic mapping of a projected carrier-specific, delivery-service-specific route, and associated projected delivery date, time and rate for a user-selected carrier and delivery service/method. Exemplary embodiments of the present invention would then track shipping/mailing progress and delivery status of the item according to carrier-provided shipping/mailing progress and delivery status “events,” such as, for example, carrier-provided item scanning events.

Abstract: The present invention relates to novel compounds, pharmaceutical compositions containing such compounds and to their use in therapy.

Abstract: Apparatuses, methods, systems, and program products are disclosed for secure data handling and storage. An apparatus includes a lock module that receives a request to decrypt encrypted data that is stored in a data repository, the encrypted data encrypted using a first encryption key, and unlocks an encryption engine in response to the request. An encryption engine may be unlocked using a master key that is generated based on combination of a plurality of keys held by a plurality of key holders. An apparatus includes a decryption module that decrypts encrypted data using an encryption engine. Encrypted data may be decrypted using a first encryption key. An apparatus includes an encryption module that re-encrypts decrypted data using an encryption engine. Decrypted data may be re-encrypted with a second encryption key that is different than a first encryption key and stored in a data repository.

Abstract: The present invention relates to novel compounds, pharmaceutical compositions containing such compounds and to their use in therapy.

Abstract: The present invention relates to compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and to their use in therapy.

Abstract: The present invention relates to compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and to their use in therapy.

Abstract: Exemplary embodiments of the present invention would determine exemplary projected routes, delivery dates, times and rates for multiple carriers and multiple delivery services/methods. Exemplary embodiments would generate and provide an exemplary interactive graphic comparison mapping of the exemplary projected carrier-specific, delivery-service-specific routes, and associated projected delivery dates, times and rates. Exemplary embodiments of the present invention would generate and provide an exemplary interactive graphic mapping of a projected carrier-specific, delivery-service-specific route, and associated projected delivery date, time and rate for a user-selected carrier and delivery service/method. Exemplary embodiments of the present invention would then track shipping/mailing progress and delivery status of the item according to carrier-provided shipping/mailing progress and delivery status “events,” such as, for example, carrier-provided item scanning events.

Abstract: The present invention is directed to pyrazole derivatives, pharmaceutical compositions comprising the compounds and the use of the compounds or the compositions in the treatment of various diseases.

Abstract: The present invention relates to compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and to their use in therapy.

Abstract: The present invention relates to compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and to their use in therapy

Abstract: The present invention relates to novel compounds, pharmaceutical compositions containing such compounds and to their use in therapy.

Abstract: According to an aspect of the invention, there is provided a communication system for communicating between a ranged weapon and a projectile for that ranged weapon, the system comprising: a transmitter associated with the ranged weapon, the transmitter being arranged to encode data to be transmitted to the projectile on an electromagnetic carrier wave, and to transmit that electromagnetic carrier wave to the projectile; a receiver associated with the projectile, the receiver being arranged to receive the electromagnetic carrier wave, and to decode data encoded in the electromagnetic carrier wave to retrieve that data, the data being usable in the activation of a fuse of the projectile.

Abstract: The present invention is directed to pyridyl derivatives which are bromodomain inhibitors, pharmaceutical compositions comprising the compounds and the use of the compounds or the compositions in the treatment of various diseases or conditions.

Abstract: The present invention relates to compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and to their use in therapy.

Abstract: Compounds of formula (I): wherein X, Y, R1 and R3-R11 are as herein defined, and salts thereof are PAD4 inhibitors and may be useful in the treatment of various disorders, for example rheumatoid arthritis, vasculitis, systemic lupus erythematosus, ulcerative colitis, cancer, cystic fibrosis, asthma, cutaneous lupus erythematosis, and psoriasis.

Abstract: The present invention relates to compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and to their use in therapy.